Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00586729 · ClinicalTrials.gov registry record · NA

Vashe Wound Therapy Study

A NA study of Burns, sponsored by Valleywise Health.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT00586729 is a NA study of Burns that has completed, run by Valleywise Health. The registered enrollment target is 23 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00586729, a NA study of Burns, has completed, sponsored by Valleywise Health.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatment duration of 5 days.

Conditions Studied

Interventions

  • DEVICE Vashe
  • DRUG Mafenide acetate

Study Locations (1)

Arizona

  • Maricopa Integrated Health System - Phoenix

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2009-07
Est. Completion 2010-11
Phase NA

Sponsor

Valleywise Health

9 total trials

What the Registry Record Tells You About NCT00586729

The ClinicalTrials.gov registry entry for NCT00586729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 36 other Burns trials with a reported enrollment target (72% lower). The listed sponsor is Valleywise Health, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Burns appearing as the primary indexed condition, and to 2 interventions - of which Vashe is the first listed.

NCT00586729 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT00586729 about?

NCT00586729 is a clinical study titled "Vashe Wound Therapy Study". This study will evaluate the efficacy, safety, and tolerability of topical Vashe™ Wound Therapy applied to gauze dressing every 6 hours or as necessary to keep dressing moist versus 5% Mafenide Acetate applied to gauze dressing every 6 hours or as necessary to keep dressing moist for a total treatme...

What is the current status of trial NCT00586729?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2009-07. Estimated completion is 2010-11.

What conditions does trial NCT00586729 study?

This clinical trial studies the following conditions: Burns.

What interventions are being tested in trial NCT00586729?

The interventions under investigation include: Vashe (DEVICE), Mafenide acetate (DRUG).

Who is sponsoring clinical trial NCT00586729?

This trial is sponsored by Valleywise Health, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00586729 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Burns

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.